Market Update (NYSE:ACT): Actavis Announces Intention to Adopt "Allergan" Corporate Name

[PR Newswire] – DUBLIN, Feb. 18, 2015 /PRNewswire/ — Actavis plc (ACT) today announced that it will adopt a new corporate name – Allergan – following the anticipated successful completion of the acquisition . . . → Read More: Market Update (NYSE:ACT): Actavis Announces Intention to Adopt "Allergan" Corporate Name Similar Articles: Stock Update: Actavis plc (NYSE:ACT) – Actavis to Divest Pharmatech to TPG Company Update: Actavis plc (NYSE:ACT) – Actavis Launches U.S. Generic Specialty Injectable Portfolio Stock Update (NYSE:ACT): Actavis to Present at 33rd Annual J.P. Morgan Healthcare Conference